Urocancer webbinarium.

Registrations are closed


Online webinar: First line systemic therapy in metastatic renal cell carcinoma
Date: 2nd of May 2022
Time: 16.00-17.00 CET


Preliminary agenda

16:00 – 16:05 Welcome

16:05 – 16:35 Lecture with Dr. Neeraj Agarwal

16:35 – 16:50 Questions and discussion with invited panel:
Dr. Sven Lundstam, Associate Professor, Chief Physician Urology, Sahlgrenska University Hospital, Gothenburg and Dr. Fabian Hofmann, Supervising Senior Assossiate, Renal Cell Carcinoma Guidlines panel European Association of Urology, Sunderby Sjukhus

Dr. Neeraj Agarwal

Dr. Neeraj Agarwal is a Professor of medicine, and a Presidential Endowed Chair of Cancer Research at the Huntsman Cancer Institute (HCI), University of Utah. He also directs the Genitourinary Oncology (GU) Program, and the Center of Investigational Therapeutics (CIT) at the HCI.

Dr. Agarwal is an internationally recognized physician scientist in the field of genitourinary cancers.  He is the overall study chair of multiple Phase I/II and Phase III trials, and serves as a steering committee member of numerous other trials. He has received SWOG Young Investigator Award, the William D. Odell Young Investigator Award, and a National Cancer Institute Cancer Clinical Investigator Team Leadership Award. After receiving his medical training at the All India Institute of Medical Sciences in New Delhi, he completed a residency in internal medicine and a fellowship in geriatric medicine at the University of Iowa, followed by a hematology-oncology fellowship at HCI.

Dr. Agarwal has authored more than 300 peer-reviewed articles and book chapters. He serves as a panel member for the NCCN guideline committees for bladder and kidney cancers. He is an advisor to the Oncology Drug Advisory Committee and the United States Food and Drug Administration, and leads early therapeutics in the SWOG genitourinary cancers committee. He holds numerous scientific communications leadership roles, including chief editor of the ASCO Daily News, specialty editor for ASCO’s site, and editorial board member of several journals, including Journal of Clinical Oncology. He also serves as a member of the ASCO Genitourinary Cancers Advisory Panel. Recently, Dr. Agarwal was appointed as the Senior Director for Clinical Research Innovation, directly reporting to the cancer center director at the Huntsman Cancer Institute.

Thanks to our sponsors!

Date & Time
2 May 2022
16:00 17:00 Europe/Stockholm

Mediahuset i Göteborg AB, Eventavdelningen

031-797 27 80

Find out what people see and say about this event, and join the conversation.